𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic value of P-glycoprotein expression in bone and soft-tissue sarcoma

✍ Scribed by O. Yamamoto; T. Wada; M. Takahashi; S. Yamawaki; S. Ishii

Publisher
Springer
Year
2000
Tongue
English
Weight
290 KB
Volume
5
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Flow cytometric analysis of P-glycoprote
Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas
✍ Hiroshi Kunikane; Mark M. Zalupski; Cheppail Ramachandran; Mark A. KuKuruga; Dav πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

Twenty-two fresh surgical specimens of human sarcomas (soft tissue and bone) from 20 patients were analyzed by flow cytometry for the expression of drug resistance-related P-glycoprotein (P-gp) and cellular daunorubicin (DNR) accumulation with or without the presence of DNR efflux blockers. Single-c

Prognostic significance of CD100 express
Prognostic significance of CD100 expression in soft tissue sarcoma
✍ EweSeng Ch'ng; Yasuhiko Tomita; Binglin Zhang; Juxiang He; Yoshihiko Hoshida; Yi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 301 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. CD100, a class IV semaphorin, promotes angiogenesis, invasive growth, proliferation, and antiapoptosis of cancer cells in vitro. The expression of CD100 in soft tissue sarcoma (STS) and its correlation with clinicopathologic factors and prognostic significance were evalu

PML expression in soft tissue sarcoma: P
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy
✍ Bruno Vincenzi; Daniele Santini; Gaia Schiavon; Anna Maria Frezza; Marianna Sill πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract Soft tissue sarcomas are aggressive tumors representing <1% of all adult neoplasms. Aim of our study was to evaluate promyelocytic leukemia gene expression value as prognostic factor and as a factor predicting response to alkylating agents/antracycline‐based first line therapy. One hund